Gyeonggi-do, South Korea

Aptabio Therapeutics Inc.


USPTO Granted Patents = 6


Forward Citations = 2

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Sung Hwan Moon (6 out of 21 patents)

silverMedal Soo Jin Lee (6 out of 10 patents)

bronzeMedal Sung Chan Lee (3 out of 15 patents)

4.  Yoo-Kyung Goh (3 out of 3 patents)

5.  Eun Jung Shin (2 out of 2 patents)

6.  Yun Soo Bae (1 out of 14 patents)

7.  Sooho Ban (1 out of 1 patent)

8.  Eunsil Lee (1 out of 1 patent)

9.  Hyunkyung Yu (1 out of 1 patent)

10.  Soo Ho Ban (1 out of 1 patent)

11.  Eun Sil Lee (1 out of 1 patent)

12.  Hyun Kyung Yu (1 out of 1 patent)

13.  Dae Ryong Cha (1 patent)

14.  Young Sun Kang (1 patent)

15.  Jin Joo Cha (1 patent)


6 patents:

Company Overview
Aptabio Therapeutics Inc. is a biotechnology company focused on developing novel therapeutics for autoimmune and inflammatory diseases. Our mission is to improve the lives of patients by delivering innovative treatments that target the underlying causes of these debilitating conditions. Through cutting-edge research and collaborations with top academic institutions, we are advancing a pipeline of potential breakthrough therapies. With a strong team of experienced scientists and leaders, we are committed to making a meaningful impact in the field of autoimmune disease research.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#109 in Gyeonggi-do

#1,620 in South Korea

Gyeonggi-do, KR
Gyeonggi-do, South Korea
Forward Citations = 2

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aptabio Therapeutics Inc.. Retrieved from https://idiyas.com/company/aptabio-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…